The relationship between synaptic excitation and inhibition (E/I ratio), two opposing forces in the mammalian cerebral cortex, affects many cortical functions such as feature selectivity and gain 1,2 . Individual pyramidal cells show stable E/I ratios in time despite fluctuating cortical activity levels. This is because when excitation increases, inhibition increases proportionally through the increased recruitment of inhibitory neurons, a phenomenon referred to as excitation-inhibition balance 3-9 . However, little is known about the distribution of E/I ratios across pyramidal cells. Through their highly divergent axons, inhibitory neurons indiscriminately contact most neighbouring pyramidal cells 10, 11 . Is inhibition homogeneously distributed 12 or is it individually matched to the different amounts of excitation received by distinct pyramidal cells? Here we discover that pyramidal cells in layer 2/3 of mouse primary visual cortex each receive inhibition in a similar proportion to their excitation. As a consequence, E/I ratios are equalized across pyramidal cells. This matched inhibition is mediated by parvalbumin-expressing but not somatostatin-expressing inhibitory cells and results from the independent adjustment of synapses originating from individual parvalbumin-expressing cells targeting different pyramidal cells. Furthermore, this match is activitydependent as it is disrupted by perturbing pyramidal cell activity. Thus, the equalization of E/I ratios across pyramidal cells reveals an unexpected degree of order in the spatial distribution of synaptic strengths and indicates that the relationship between the cortex's two opposing forces is stabilized not only in time but also in space.
The relationship between synaptic excitation and inhibition (E/I ratio), two opposing forces in the mammalian cerebral cortex, affects many cortical functions such as feature selectivity and gain 1, 2 . Individual pyramidal cells show stable E/I ratios in time despite fluctuating cortical activity levels. This is because when excitation increases, inhibition increases proportionally through the increased recruitment of inhibitory neurons, a phenomenon referred to as excitation-inhibition balance [3] [4] [5] [6] [7] [8] [9] . However, little is known about the distribution of E/I ratios across pyramidal cells. Through their highly divergent axons, inhibitory neurons indiscriminately contact most neighbouring pyramidal cells 10, 11 . Is inhibition homogeneously distributed 12 or is it individually matched to the different amounts of excitation received by distinct pyramidal cells? Here we discover that pyramidal cells in layer 2/3 of mouse primary visual cortex each receive inhibition in a similar proportion to their excitation. As a consequence, E/I ratios are equalized across pyramidal cells. This matched inhibition is mediated by parvalbumin-expressing but not somatostatin-expressing inhibitory cells and results from the independent adjustment of synapses originating from individual parvalbumin-expressing cells targeting different pyramidal cells. Furthermore, this match is activitydependent as it is disrupted by perturbing pyramidal cell activity. Thus, the equalization of E/I ratios across pyramidal cells reveals an unexpected degree of order in the spatial distribution of synaptic strengths and indicates that the relationship between the cortex's two opposing forces is stabilized not only in time but also in space.
To determine the distribution of E/I ratios among layer 2/3 neighbouring pyramidal cells ( Fig. 1a ), we used adeno-associated virus (AAV) to conditionally express channelrhodopsin-2 (ChR2) [13] [14] [15] in Scnn1a-Cre-Tg3 mice and photoactivated layer 4 excitatory neurons, one of the main sources of synaptic excitation to layer 2/3, in acute visual cortical slices (Extended Data Fig. 1 ). We compared the E/I ratios between two to four simultaneously recorded layer 2/3 pyramidal cells (inter-soma distance 39.4 6 2.5 mm, mean 6 s.e.m.; Extended Data Fig. 2 ) voltage clamped alternatively at the reversal potential for synaptic inhibition and excitation to isolate excitatory postsynaptic currents (EPSCs) and disynaptic inhibitory postsynaptic currents (IPSCs), respectively. EPSC amplitudes greatly varied between simultaneously recorded neurons and so did IPSC amplitudes (Fig. 1b ). Despite the heterogeneous distributions of EPSC and IPSC amplitudes among pyramidal cells, however, we found a strong correlation between their amplitudes. That is, neurons with larger EPSCs also received larger IPSCs (Fig. 1c, e ). As a consequence, the distribution of E/I ratios across pyramidal cells varied much less than the distributions of EPSC and IPSC amplitudes ( Fig. 1d, f ) and much less than if EPSCs and IPSCs were randomly paired between cells (Extended Data Fig. 2 ). These data indicate that E/I ratios are equalized across pyramidal cells.
This equalization could occur if distinct layer 2/3 pyramidal cells each receive inhibition from a 'private' set of inhibitory neurons such that the excitatory afferents that more strongly excite a pyramidal cell also more strongly excite its private inhibitory neurons. However, the two classes of inhibitory neurons, parvalbumin-expressing (Pvalb) and somatostatinexpressing (Sst) cells, that provide most inhibition to layer 2/3 pyramidal 1 Neurobiology Section, Division of Biological Sciences, Center for Neural Circuits and Behavior, University of California, San Diego, La Jolla, California 92093-0634, USA. 2 cells showed broad connectivity with pyramidal cells (97% and 93%, respectively, Fig. 1g ), as previously shown 10, 11 , thus precluding the private connectivity. Alternatively, the correlation between excitation and inhibition could be an artefact of the slicing procedure, whereby damaged neurons receive less excitation and less inhibition. To address this possibility we used an independent marker to identify neurons receiving more excitation. We used mice in which the promoter of the activity-dependent immediate early gene Fos drives the expression of Fos fused to the enhanced green fluorescent protein (Fos-EGFP), because in these mice EGFP 1 neurons receive more excitation than EGFP 2 neurons 16 . EGFP 1 neurons were predominantly pyramidal cells (Extended Data Fig. 3 ). We photostimulated layer 4 in acute slices from Fos-EGFP, Scnn1a-Cre-Tg3 mice and simultaneously recorded pairs of EGFP 1 and nearby EGFP 2 layer 2/3 pyramidal cells. Layer 4 activation generated larger EPSCs in EGFP 1 neurons in 78% of all recorded pairs, and EGFP 1 neurons received, on average, 40% larger EPSCs ( Fig. 2a, b ) (the average logarithm of EGFP 1 / EGFP 2 ratios was 0.15). Importantly, EGFP 1 neurons also received larger disynaptic IPSCs ( Fig. 2a, c) . Consequently, the E/I ratios of EGFP 1 and EGFP 2 neurons were similar ( Fig. 2d ).
Taken together, these results demonstrate that excitation and inhibition, despite varying in amplitudes between pyramidal cells, remain proportional to each other, thus equalizing E/I ratios.
Which type of interneuron provides the inhibition that matches layer-4-mediated excitation? We took advantage of the fact that EGFP 1 neurons in Fos-EGFP mice receive larger excitation from layer 4 and crossed them to Pvalb-ires-Cre or Sst-ires-Cre mice to express ChR2 conditionally. Photoactivation of Pvalb cells generated larger monosynaptic IPSCs in EGFP 1 than in EGFP 2 neurons ( Fig. 2e, f) . In contrast, Sst cells generated IPSCs whose amplitudes did not correlate with EGFP expression ( Fig. 2g, h) . These data indicate that Pvalb cells, but not Sst cells, provide stronger inhibition onto neurons that receive stronger layer-4-mediated excitation, thereby contributing to the equalization of E/I ratios.
What mechanism regulates the strengths of excitation and/or inhibition to achieve the observed proportionality? Excitation and inhibition may reach their specific ratio by using the pyramidal cell's activity as a measure of their relative strengths. For example, the low activity caused by a strong Pvalb-cell-mediated inhibition or by a weak layer-4mediated excitation could be the signal to increase layer-4-mediated excitation or to decrease Pvalb-cell-mediated inhibition, respectively, until a neuron's specific higher set-point activity is reached. In both possibilities the initially small E/I ratio is increased by either increasing excitation to match the large inhibition or by decreasing inhibition to match the small excitation. Both possibilities are plausible since the activity of individual neurons can regulate the strengths of both excitatory and inhibitory synapses [17] [18] [19] [20] . If this hypothesis is correct, perturbing the activity of pyramidal cells should disrupt the proportionality between excitation and inhibition. For example, reducing the excitability of a pyramidal cell should increase its E/I ratio by either increasing excitation (the first possibility), or decreasing inhibition (the second possibility), or both.
We reduced the excitability of a small, random subset of layer 2/3 pyramidal cells in primary visual cortex (V1) by overexpressing a Kir2.1 channel via in utero electroporation (IUE) [21] [22] [23] (Fig. 3a ). Recordings in acute slices confirmed the reduced excitability in Kir2.1-overexpressing cells (Kir2.1 neurons) compared with untransfected control pyramidal cells (Extended Data Fig. 4 ). In vivo targeted recordings from Kir2.1 and nearby control neurons (Fig. 3b , c) demonstrated that Kir2.1 overexpression drastically suppressed visual-evoked and spontaneous activity ( Fig. 3d-f ). We then examined the impact of this perturbation on excitation and inhibition. We photostimulated layer 4 and simultaneously recorded Kir2.1 and neighbouring control neurons in the acute slices from Scnn1a-Cre-Tg3 mice. Surprisingly, layer-4-mediated excitation was not significantly different between these two groups (Fig. 3g, h) , invalidating the first aforementioned possibility. In contrast, disynaptic inhibition was significantly smaller in Kir2.1 neurons ( Fig. 3g, i) , consistent with the second possibility. The effect on inhibition was due to the channel function of Kir2.1 because a non-conducting Kir2.1 mutant (Extended Data Fig. 4 ) had no effect (Extended Data Fig. 5 ). Thus, perturbing layer 2/3 pyramidal cell excitability disrupts the proportionality between excitation and inhibition ( Fig. 3j ). These data indicate that pyramidal cell activity contributes to the equalization of E/I ratios across pyramidal cells.
If pyramidal cell activity contributes to establishing the proportionality between layer-4-mediated excitation and Pvalb-cell-mediated inhibition, then the decrease in excitability should selectively decrease 
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Pvalb-but not Sst-cell-mediated inhibition. Conversely, an increase in excitability should selectively increase Pvalb-cell-mediated inhibition. Indeed, Pvalb-cell-mediated inhibition was significantly smaller in Kir2.1 than in control neurons, whereas Sst-cell-mediated inhibition was similar ( Fig. 4a-e ). Overexpression of the non-conducting Kir2.1 mutant did not affect Pvalb-cell-mediated inhibition (Extended Data Fig. 5 ).
We used a bacterial voltage-gated Na 1 channel (mNaChBac) to enhance neuronal excitability. Neurons expressing mNaChBac generate 
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long-lasting action potentials and depolarization of the order of hundreds of milliseconds (Extended Data Fig. 6 ). Because constitutive expression of mNaChBac in cortical neurons from embryonic day 15.5 (E15.5) caused a neuronal migration defect (Extended Data Fig. 7 ), we devised a Flpo recombinase-mediated flip-excision strategy, F-FLEX switch (Extended Data Fig. 8 ), to conditionally express mNaChBac postnatally. We combined in utero electroporation of a Flpo-dependent mNaChBac-expressing plasmid, to randomly transfect a small subset of layer 2/3 pyramidal cells, with injection of an AAV expressing Flpo at postnatal day 1 (P1), to turn on mNaChBac expression. This allowed us to concurrently express ChR2 in Pvalb or Sst cells, and mNaChBac in layer 2/3 pyramidal cells without affecting their migration (Extended Data Fig. 7 ). Pvalb-cell-mediated inhibition was significantly larger in mNaChBac neurons than in control neurons ( Fig. 4f-h) , and a nonconducting mNaChBac mutant (Extended Data Fig. 6 ) had no effect (Extended Data Fig. 5 ). mNaChBac expression did not alter Sst-cellmediated inhibition (Fig. 4i, j) . To determine whether also more acute perturbations of layer 2/3 pyramidal cell excitability alter Pvalb-cellmediated inhibition, we used Flpo and F-FLEX switch to express Kir2.1 or mNaChBac for only approximately 1 week starting around postnatal days 12-14. This acute decrease (Kir2.1) or increase (mNaChBac) in excitability caused a decrease or an increase in Pvalb-cell-mediated inhibition, respectively, similar to the changes caused by the chronic expression of Kir2.1 or mNaChBac ( Fig. 4a -c, f-h). These data indicate that the proportionality between layer-4-mediated excitation and Pvalbcell-mediated inhibition is equalized across pyramidal cells through the bidirectional modulation of the strength of Pvalb cell synapses.
The above results show that the spatial heterogeneity of Pvalb-cellmediated inhibition ensures the equalization of E/I ratios across pyramidal cells. Is the inhibition mediated by a single Pvalb cell also heterogeneous across its targeted pyramidal cells? We first determined whether the relative amplitudes of unitary IPSCs (uIPSCs) mediated by a Pvalb cell onto its targets are predicted by the relative activity of these targets. We suppressed the activity of a small subset of layer 2/3 pyramidal cells by overexpressing Kir2.1 and simultaneously recorded from a layer 2/3 Pvalb cell, a control and a Kir2.1 neuron (Fig. 5a ). Although the Pvalbto-pyramidal cell connectivity was similarly high, regardless of whether pyramidal cells overexpressed Kir2.1 (Fig. 5f ), uIPSC amplitude was significantly smaller in Kir2.1 neurons than in control neurons (Fig. 5b, f) . All properties of the unitary connections between Pvalb cells and control neurons were similar to those recorded in mice that were not transfected with Kir2.1 (Extended Data Fig. 9 ), indicating a cell-autonomous effect of Kir2.1 overexpression. We assessed the variability of uIPSC amplitudes originating from a single Pvalb cell and determined its dependency on the activity of the targeted pyramidal cells. We simultaneously recorded from a layer 2/3 Pvalb cell and two or three nearby pyramidal cells that were either all control or all Kir2.1 neurons (Fig. 5c, d) . uIPSC amplitudes varied greatly from one control neuron to another, but less among Kir2.1 neurons ( Fig. 5c-e, g) , possibly because suppressing pyramidal cell activity cannot reduce uIPSC amplitudes below a certain level (flooring effect) (Extended Data Fig. 10 ). Thus, the inhibition generated by even an individual Pvalb cell onto its targets is remarkably heterogeneous, and this heterogeneity reflects in part the activity profile of the targeted pyramidal cell population. Hence, despite the indiscriminate connectivity of Pvalb cells, the amount of inhibition that they provide onto each of their targets is adjusted to equalize the E/I ratios (Fig. 5h) .
Both theoretical and experimental evidence indicates that the relationship between synaptic excitation and inhibition in the cerebral cortex is fundamental for sensory processing 1, 2, [24] [25] [26] [27] . Failure to establish or maintain this relationship may be the neural basis of neurological disorders such as schizophrenia and autism 28, 29 . We discover that E/I ratios are remarkably similar across different pyramidal cells despite large variations in the amplitudes of synaptic excitation and inhibition. The activity-dependent adjustment of inhibition to match excitation may result from activity-dependent gene expression 19, 20, 30 . Our study provides insight into how two opposing synaptic inputs, layer-4-mediated excitation and Pvalb-cell-mediated inhibition, remain proportional across a population of pyramidal cells. Thus it reveals an unanticipated degree of order in the distribution of synaptic strengths in cortical space.
METHODS SUMMARY
Cre-dependent recombinant AAV vectors were injected postnatally into Creexpressing mice to conditionally express ChR2. Plasmids were electroporated in utero at embryonic day 14.5 or 15.5 to transfect a small, random subset of layer 2/3 pyramidal cells. For in vitro physiology, mice at postnatal days 14-23 were anaesthetized and transcardially perfused. Coronal slices were perfused with artificial cerebrospinal fluid for whole-cell recordings at 31 37 42 Average relative deviation 
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ChR2. For in vivo physiology, mice at postnatal days 17-23 were anaesthetized by intraperitoneal injection of chlorprothixene (5 mg kg 21 ) followed by urethane (1.2 g kg 21 ) and the body temperature was maintained at 37 uC. A craniotomy at V1 was performed and targeted loose-patch recordings were performed under the guidance of two-photon laser scanning microscopy.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 35 . Mutation Y242F blocks tyrosine kinase phosphorylation of Kir2.1 at residue Y242 to enhance its plasma membrane surface expression 36 . Three point mutations, G144A, Y145A and G146A, were introduced to generate a non-conducting channel 37 . A Myc tag (EQKLISEEDL) was fused to the amino (N) termini of Kir2.1 E224G Y242F and Kir2.1 E224G Y242F G144A Y145A G146A, referred to as Kir2.1 and Kir2.1Mut, respectively. Both Kir2.1 and Kir2.1Mut were carboxy (C)-terminally fused with a T2A sequence (GSGEGRGSLLTCGDVEENPGP) followed by a tdTomato. The resulting constructs were then cloned into a plasmid containing a CAG promoter (pCAG) to generate pCAG-Kir2.1-T2A-tdTomato and pCAG-Kir2.1Mut-T2A-tdTomato. The complementary DNA (cDNA) encoding a wild-type bacterial Na 1 channel NaChBac 38 was synthesized de novo and codon-optimized for mammalian expression (referred as mNaChBac) by DNA2.0. A point mutation E191K was introduced to generate a non-conducting channel 39 , referred as mNaChBacMut. Both mNaChBac and mNaChBacMut were C-terminally fused with T2A-tdTomato and cloned into the pCAG plasmid to create pCAG-mNaChBac-T2A-tdTomato and pCAG-mNaChBacMut-T2A-tdTomato, respectively. F-FLEX cassette using two wild-type Frt sites and two F14 sites 40 (Extended Data Fig. 8 ) was synthesized de novo and cloned into the plasmid pJ244 by DNA2.0 to generate pJ244-F-FLEX. mNaChBac-T2A-tdTomato and mNaChBacMut-T2A-tdTomato were subcloned into pJ244-F-FLEX in the inverted orientation. F-FLEX-mNaChBac-T2A-tdTomato and F-FLEX-mNaChBacMut-T2A-tdTomato cassettes were then subcloned into an AAV cis-plasmid containing an EF1a promoter to generate pAAV-EF1a-F-FLEX-mNaChBac-T2A-tdTomato and pAAV-EF1a-F-FLEX-mNaChBacMut-T2A-tdTomato, respectively. mNaChBac-T2A-tdTomato in pAAV-EF1a-F-FLEX-mNaChBac-T2A-tdTomato was replaced with inverted Kir2.1-T2A-tdTomato to generate pAAV-EF1a-F-FLEX-Kir2.1-T2A-tdTomato.
An improved version of Flp recombinase, Flpo 41 was cloned into a pCAG plasmid and an AAV cis-plasmid containing a human synapsin promoter to generate pCAG-Flpo and pAAV-hSynapsin-Flpo, respectively. pCAG-EGFP 42 , pCAG-mRFP 43 and pCAG-Cre 44 were obtained from Addgene (11150, 28311 and 13775, respectively).
HEK-293FT cells (Life Technologies) were transfected with DNA constructs (0.1-0.5 mg) in 12-well plates using Lipofectamine 2000 (Life Technologies) to test their functionality. The following constructs were used in Extended Data Fig. 8c, d : pCAG-EGFP, pCAG-mRFP, pCAG-Flpo, pCAG-Cre, pAAV-EF1a-F-FLEX-mNaChBac-T2A-tdTomato and pAAV-EF1a-DIO-hChR2(H134R)-EYFP. In utero electroporation. Female CD-1 mice were crossed with male Scnn1a-Cre-Tg3, Pvalb-ires-Cre, or Sst-ires-Cre mice to obtain timed pregnancies. pCAG-Kir2.1-T2A-tdTomato, pCAG-Kir2.1Mut-T2A-tdTomato, pCAG-mNaChBac-T2A-tdTomato, and pCAG-mNaChBacMut-T2A-tdTomato were used at the final concentrations of 2-3 mg ml 21 . pAAV-EF1a-F-FLEX-mNaChBac-T2A-tdTomato, pAAV-EF1a-F-FLEX-mNaChBacMut-T2A-tdTomato or pAAV-EF1a-F-FLEX-Kir2.1-T2A-tdTomato (2-3 mg ml 21 final concentration) was mixed with pCAG-EGFP (0.2 mg ml 21 final concentration). Fast Green (Sigma-Aldrich, 0.01% final concentration) was added to the DNA solution. On embryonic day 14.5 or 15.5, female mice were anaesthetized with 2.5% isoflurane in oxygen at a flow rate of 1 l min 21 and the body temperature was maintained by a feedback-based DC temperature control system (FHC) at 37 uC. Buprenorphine (3 mg, Reckitt Benckiser Healthcare) was administered subcutaneously along with 1 ml of Lactated Ringer's Injection (Baxter Healthcare). The abdominal fur was shaved and the skin was cleaned with 70% alcohol and iodine. A sterile towel drape was laid on the mouse with only the abdomen exposed. Midline incisions (2 cm) were made on the abdominal skin and wall, and the uteri were taken out of the abdominal cavity. A bevelled glass micropipette (tip size 100-mm outer diameter, 50-mm inner diameter) was used to penetrate the uterus and the embryo skull to inject about 1.5 ml of DNA solution into one lateral ventricle. Five pulses of current (voltage 39 V, duration 50 ms) were delivered at 1 Hz with a Tweezertrode (5-mm diameter) and a square-wave pulse generator (ECM 830, BTX Harvard Apparatus). The electrode paddles were positioned along the 70u angle to the brain's sagittal plane. The cathode faced the occipital side of the injected ventricle to target the visual cortex. After electroporation, uteri were put back into the abdominal cavity, and the abdominal wall and skin were sutured. Mice were returned to the home cage and recovered from anaesthesia on a 37 uC Deltaphase Isothermal Pad (Braintree Scientific). Additional buprenorphine (3 mg) was administered subcutaneously on the next day. After birth, transfected pups were identified by the transcranial fluorescence of tdTomato or EGFP with a stereomicroscope (MVX10 Macroview, Olympus). Only the pups in which the majority of the transfection occurred in the primary visual cortex were used for experiments. AAV production and injection. All recombinant AAV vectors were produced by the Penn Vector Core with the following titres: AAV2/9-CAGGS-Flex-ChR2-tdTomato 45 (Addgene 18917, titre 1.15 3 10 13 genome copies per millilitre), AAV2/1-CAGGS-Flex-ChR2-tdTomato (titre 6.86 3 10 12 or 1.22 3 10 13 genome copies per millilitre), AAV2/9-EF1a-DIO-hChR2(H134R)-EYFP 46 (Addgene 20298, titre 6.24 3 10 12 or 1.18 3 10 13 genome copies per millilitre), AAV2/1-EF1a-DIO-hChR2 (H134R)-EYFP (titre 3.41 3 10 13 genome copies per millilitre) and AAV2/9-hSynapsin-Flpo (titre 1.57 3 10 13 genome copies per millilitre).
Injection at postnatal days 0-2. AAV was injected into the V1 of pups using a Nanoject II nanolitre injector (Drummond Scientific Company). Pups were anaesthetized by hypothermia and secured on a custom-made plate. Fast Green (0.01% final concentration) was added to the virus solution for visualization. A bevelled glass micropipette (tip size 60-mm outer diameter, 30-mm inner diameter) was used to penetrate the scalp and skull, and to inject AAV at different depths (600, 500, 400 and 300 mm below the scalp) of one location (1.6 mm lateral and 0.3 mm caudal from the lambda). A total of about 80-180 nl (adjusted based on the virus titres) of virus solution was injected over 60 s. After injection, the micropipette was kept in the parenchyma at 300-mm depth for 30 s before being slowly withdrawn. Pups were placed on a 37 uC Deltaphase Isothermal Pad to recover from anaesthesia and then were returned to the dam. For chronic expression of mNaChBac or mNaChBacMut, a mix of AAV2/9-hSynapsin-Flpo (titre 1.57 3 10 13 genome copies per millilitre) and AAV2/9-EF1a-DIO-hChR2(H134R)-EYFP (titre 1.18 3 10 13 genome copies per millilitre) at a ratio of 1:3 was injected on postnatal day 1.
Injection at postnatal days 12-14. For acute expression of Kir2.1 or mNaChBac, mice previously injected with AAV2/1-EF1a-DIO-hChR2(H134R)-EYFP between postnatal days 0 and 2 were injected with AAV2/9-hSynapsin-Flpo between postnatal days 12 and 14. Mice were anaesthetized with 2.5% isoflurane in oxygen at a flow rate of 1 l min 21 and the body temperature was maintained by a feedbackbased DC temperature control system at 37 uC. Buprenorphine (1 mg) was administered subcutaneously along with 0.1 ml of Lactated Ringer's Injection. Lubricant ophthalmic ointment (Artificial Tears Ointment, Rugby Laboratories) was applied to the corneas to prevent drying. The scalp fur was shaved and the skin was cleaned with 70% alcohol and iodine. A small incision (0.5 cm) was made on the skin medial to the visual cortex. The skull at the injection site (2.5 mm lateral to the midline and 1 mm rostral to the lambda suture; the same site that was previously electroporated in utero and virally injected between postnatal days 0 and 2) was thinned with a 0.3-mm diameter round bur (Busch Bur, Gesswein) on a high-speed rotary micromotor (Foredom) such that the injection glass micropipette (tip size 50-mm outer diameter, 25-mm inner diameter) could penetrate the skull. A total of 150 nl of virus solution was injected 450 mm below the skull at a rate of 20 nl min 21 using an UltraMicroPump III and a Micro4 controller (World Precision Instruments). After the injection, the micropipette was kept in the parenchyma for 5-10 min before being slowly withdrawn. The skin was sutured. Mice were returned to their home cage to recover from anaesthesia on a 37 uC Deltaphase Isothermal Pad. Immunocytochemistry. Mice were anaesthetized by an intraperitoneal injection of a ketamine and xylazine mix (100 mg kg 21 and 10 mg kg 21 , respectively), and were transcardially perfused with phosphate buffered saline (PBS, pH 7.4) followed by 4% paraformaldehyde in PBS (pH 7.4). Brains were removed, further fixed overnight in 4% paraformaldehyde, cryoprotected with 30% sucrose in PBS and frozen in optimum cutting-temperature medium until sectioning. A HM 450 Sliding Microtome (Thermo Scientific) was used to section the brains to obtain 30-50-mm coronal slices. Slices were blocked with 1% bovine serum albumin, 2% normal goat serum and 0.3% TritonX-100 in PBS at room temperature for 1 h and incubated with primary antibodies in working buffer (0.1% bovine serum albumin, 0.2% normal goat serum, 0.3% TritonX-100 in PBS) at 4 uC overnight. The following primary antibodies were used: rabbit anti-RFP (1:200, Abcam), rat anti-RFP (1:300, Chromotek), chicken anti-GFP (1:500, Aves Labs), rabbit anti-GFP (1:2000, Life Technologies) and mouse anti-NeuN (1:200, Millipore). The slices were washed four times with working buffer for 10 min each, incubated with secondary antibodies conjugated with Alexa Fluor 488, 594 or 647 (1:500 or 1:1,000, Life Technologies) in working buffer for 1 h at room temperature, and then washed four times with working buffer for 10 min each. NeuroTrace 435/455 blue fluorescent Nissl stain (1:200, Life Technologies) was used to label neurons after antibody staining. Slices were mounted in Vectashield Mounting Medium containing 49,6-diamidino-2phenylindole (DAPI) (Vector Laboratories) or ProLong Gold antifade reagent (Life Technologies). Images were acquired on an Olympus FV1000 Confocal, a Zeiss
Axio Imager A1 or an Olympus MVX10 Macroview, and processed using National Institutes of Health ImageJ. To estimate the fraction of layer 2/3 pyramidal cells that were transfected by in utero electroporation (Fig. 3a) , transfected neurons (tdTomato1) and total neurons (NeuN1) in layer 2/3 were visually quantified. Assuming that 13.2% of layer 2/3 neurons are inhibitory interneurons (Extended Data Fig. 3 ), we estimated that 9 6 1% (mean 6 s.e.m., n 5 12 sections from six mice) of layer 2/3 pyramidal cells were transfected. In vitro physiology. Mice between postnatal days 14 and 23 were anaesthetized by an intraperitoneal injection of a ketamine and xylazine mix (100 mg kg 21 and 10 mg kg 21 , respectively), and transcardially perfused with cold (0-4 uC) slice cutting solution containing 80 mM NaCl, 2.5 mM KCl, 1.3 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 4 mM MgCl 2 , 0.5 mM CaCl 2 , 20 mM D-glucose, 75 mM sucrose and 0.5 mM sodium ascorbate (315 mosmol, pH 7.4, saturated with 95% O 2 /5% CO 2 ). Brains were removed and sectioned in the cutting solution with a Super Microslicer Zero1 (D.S.K.) to obtain 300-mm coronal slices. Slices were incubated in a custom-made interface holding chamber saturated with 95% O 2 /5% CO 2 at 34 uC for 30 min and then at room temperature for 20 min to 8 h until they were transferred to the recording chamber.
Recordings were performed on submerged slices in artificial cerebrospinal fluid (ACSF) containing 119 mM NaCl, 2.5 mM KCl, 1.3 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 1.3 mM MgCl 2 , 2.5 mM CaCl 2 , 20 mM D-glucose and 0.5 mM sodium ascorbate (300 mosmol, pH 7.4, saturated with 95% O 2 /5% CO 2 , perfused at 3 ml min 21 ) at 31-32 uC. For whole-cell recordings, we used a K 1 -based pipette solution containing 142 mM K 1 -gluconate, 10 mM HEPES, 1 mM EGTA, 2.5 mM MgCl 2 , 4 mM ATP-Mg, 0.3 mM GTP-Na, 10 mM Na 2 -phosphocreatine (295 mosmol, pH 7.35) or a Cs 1 -based pipette solution containing 115 mM Cs 1 -methanesulphonate, 10 mM HEPES, 1 mM EGTA, 1.5 mM MgCl 2 , 4 mM ATP-Mg, 0.3 mM GTP-Na, 10 mM Na 2 -phosphocreatine, 2 mM QX 314-Cl, 10 mM BAPTA-tetracesium (295 mosmol, pH 7.35). Membrane potentials were not corrected for liquid junction potential (experimentally measured as 11.4 mV for the K 1 -based pipette solution and 8.4 mV for the Cs 1 -based pipette solution).
Neurons were visualized with video-assisted infrared differential interference contrast imaging and fluorescent neurons were identified by epifluorescence imaging under a water immersion objective (340, 0.8 numerical aperture) on an upright Olympus BX51WI microscope with an infrared CCD camera (VX44, Till Photonics). For Fos-EGFP experiments, in a given field-of-view those pyramidal cells with the strongest EGFP fluorescence were visually identified as the EGFP1 neurons. The EGFP2 neurons were those pyramidal cells whose fluorescence was equal to the background fluorescence level of the slices.
Data were low-pass filtered at 4 kHz and acquired at 10 kHz with an Axon Multiclamp 700A or 700B amplifier and an Axon Digidata 1440A Data Acquisition System under the control of Clampex 10.2 (Molecular Devices). Data were analysed offline using AxoGraph X (AxoGraph Scientific).
For the photostimulation of ChR2-expressing neurons, blue light was emitted from a collimated light-emitting diode (470 nm) driven by a T-Cube LED Driver (Thorlabs) under the control of an Axon Digidata 1440A Data Acquisition System and Clampex 10.2. Light was delivered through the reflected light fluorescence illuminator port and the 340 objective.
Synaptic currents were recorded in the whole-cell voltage clamp mode with the Cs 1 -based patch pipette solution. Only recordings with series resistance below 20 MV were included. EPSCs and IPSCs were recorded at the reversal potential for IPSCs (260 mV) and EPSCs (110 mV), respectively. For light pulse stimulation, pulse duration (0.5-5 ms) and intensity (1.1-5.5 mW mm 22 ) were adjusted for each recording to evoke small (to minimize voltage-clamp errors; see the figures for the ranges) but reliable monosynaptic EPSCs or IPSCs. Disynaptic IPSCs were evoked using the same light pulses that were used for evoking the corresponding monosynaptic EPSCs. Light pulses were delivered at 30-s interstimulus intervals.
To quantify the inter-cell variability of EPSCs (Fig. 1d, f) , we used the average relative deviation defined as 1 N|EPSC mean
the number of pyramidal cells in one given experiment, EPSC i is the amplitude of the EPSC recorded in the i th pyramidal cell within that experiment and EPSC mean is the mean amplitude of EPSCs recorded across pyramidal cells in the same experiment. The average relative deviation of IPSCs or E/I ratios was obtained in the same way for each experiment (Fig. 1d, f) .
To record unitary connections between inhibitory neurons and pyramidal cells, Pvalb and Sst cells were identified by the Cre-dependent expression of ChR2-tdTomato or hChR2(H134R)-EYFP in Pvalb-ires-Cre and Sst-ires-Cre mice, respectively. Pyramidal cells were first recorded in whole-cell voltage clamp mode (110 mV) with the Cs 1 -based patch pipette solution, and a nearby Pvalb or Sst cell was subsequently recorded in the whole-cell current clamp mode with the K 1based patch pipette solution. Action potentials were elicited in Pvalb or Sst cells by a 2-ms depolarizing current step (1-2 nA) with a 15-s interstimulus intervals.
Unitary IPSC (uIPSC) amplitudes were measured from the average of 10-50 sweeps. We considered a Pvalb or Sst cell to be connected with a pyramidal cell when the average uIPSC amplitude was at least three times the baseline standard deviation. The average relative deviation of uIPSC amplitudes ( Fig. 5 and Extended Data Fig. 9 ) was calculated as 1 N|uIPSC mean
the number of pyramidal cells in one given experiment, uIPSC i is the amplitude of the IPSC recorded in the i th pyramidal cell within that experiment and uIPSC mean is the mean amplitude of uIPSCs recorded across pyramidal cells in the same experiment. Neuronal intrinsic excitability was examined with the K 1 -based pipette solution in the presence of the AMPA receptor antagonist NBQX (10 mM), the NMDA receptor antagonist (RS)-CPP (10 mM) and the GABA A (c-aminobutyric acid) receptor antagonist SR 95531 (10 mM). The resting membrane potential was recorded in the whole-cell current clamp mode within the first minute after break-in. The input resistance was measured after balancing the bridge by injecting a 500-ms-long hyperpolarizing current pulse (10-100 pA) to generate a small membrane potential hyperpolarization (2-10 mV) from the resting membrane potential. Depolarizing currents were increased in 5-or 10-pA steps to identify rheobase currents.
Ba 21 -sensitive currents were measured with the K 1 -based pipette solution in the presence of NBQX (10 mM), (RS)-CPP (10 mM), SR 95531 (10 mM) and Na 1 channel blocker TTX (1 mM). Only recordings with series resistance below 20 MV were included. Neurons were clamped at 225 mV and the membrane potential was ramped to 2125 mV at a rate of 20 mV s 21 . The membrane currents recorded in the presence of BaCl 2 (50 mM) were subtracted from those recorded in the absence of BaCl 2 to obtain the Ba 21 -sensitive currents, which were then divided by the wholecell membrane capacitances to calculate the current densities. In vivo physiology. Mice between postnatal days 17 and 23 were anaesthetized by an intraperitoneal injection of chlorprothixene (5 mg kg 21 ) followed by urethane (1.2 g kg 21 ). Oxygen was given at a flow rate of 1 l min 21 during the experiments and isoflurane (,0.5%) was supplemented if necessary. The body temperature was maintained by a feedback-based DC temperature control system at 37 uC. Dexamethasone sodium phosphate (2 mg kg 21 ) and Lactated Ringer's Injection (3 ml kg 21 every 2 h) were administered subcutaneously. Whiskers and eyelashes were trimmed, and a thin layer of silicone oil (kinematic viscosity 30,000 centistokes (1 cSt 5 10 26 m 2 s 21 ), Sigma-Aldrich) was applied to the corneas to prevent drying. The scalp and periosteum were removed. Vetbond tissue adhesive (3M) was applied to stabilize all sutures. A custom-made recording chamber with a 3-mm diameter hole in the centre was attached to the skull over V1 with Vetbond tissue adhesive and dental cement (Ortho-Jet BCA, Lang Dental). The recording chamber was then secured on a custom-made holder. A craniotomy (1.5-2 mm diameter, centred at 2.5 mm lateral to midline and 1 mm rostral to lambda suture) was performed with a 0.3-mm diameter round bur on a high-speed rotary micromotor. The dura was left intact and the craniotomy was covered by a thin layer of 1.5% type III-A agarose in HEPES-ACSF containing 142 mM NaCl, 5 mM KCl, 10 HEPES-Na, 1.3 mM MgCl 2 , 3.1 mM CaCl 2 and 10 mM D-glucose (310 mosmol, pH 7.4). HEPES-ACSF was added to the recording chamber.
Targeted loose-patch recordings were performed under the guidance of a twophoton laser scanning microscope. Two-photon imaging was performed with a water immersion objective (340, 0.8 numerical aperture, Olympus) on a Moveable Objective Microscope (Sutter Instruments) coupled with a Ti:Saphire laser (Chameleon Ultra II, Coherent) under the control of ScanImage 3.6 (Janelia Farm Research Campus, HHMI) 47 . Laser wavelength was tuned to 950 nm (laser power after the objective: 25-50 mW) for two-photon excitation of tdTomato and Alexa Fluor 488.
An Axon Multiclamp 700B amplifier was used for extracellular recording of spikes. A patch pipette containing HEPES-ACSF and 10-20 mM Alexa Fluor 488 hydrazide (Life Technologies) was advanced along its axis towards neurons located between 150 and 250 mm below the dura with minimal lateral movements. A small positive pressure was applied to the patch pipette to avoid clogging of the tip and to inject a small amount of fluorescent dye to stain the extracellular space. Nonfluorescent neurons were visualized as negative images 48 . The pipette resistance was constantly monitored in voltage-clamp mode. The concurrence of the pipette tip contacting the neuron and an increase in pipette resistance indicated successful targeting, which was further confirmed post hoc (see below). Upon the release of positive pressure, a small negative pressure was applied to form a loose seal (10-30 MV). The amplifier was then switched to the current-clamp mode with zero current injection to record voltage. Data were low-pass filtered at 10 kHz and acquired at 32 kHz with a NI-DAQ board (NI PCIe-6259, National Instruments) under the control of a custom-written program running in Matlab (Mathworks). Within a local region (,50 mm), neighbouring tdTomato 1 and tdTomato 2 neurons were sequentially targeted for recording, but the order of recordings from tdTomato 1 and tdTomato 2 was alternated. The correct targeting of tdTomato 1 neurons was confirmed at the end of the recording either by the filling of the neuron with the RESEARCH LETTER fluorescent dye contained in the pipette via break-in or by the presence of neuronal fluorescence in the recording pipette due to the negative pressure.
Visual stimuli were generated in Matlab with Psychophysics Toolbox 49 and displayed on a gamma-corrected liquid-crystal display monitor (30 cm 3 47.5 cm, 60 Hz fresh rate, mean luminance 50 cd m 22 ). The monitor was placed 25 cm away from the contralateral eye, covering 62u (vertical) 3 87u (horizontal) of the visual space. The monitor was approximately centred at the retinotopic location corresponding to the V1 recording site by monitoring single-unit or multi-unit activity in response to a moving bar on the screen. During recordings, full-field sinusoidal drifting gratings (temporal frequency 2 Hz, spatial frequency 0.04 cycles per degree, 100% contrast) were presented randomly at 12 different directions from 0u to 330u for 1.5 s, preceded and followed by the presentation of a grey screen for 2 s and 1.5 s, respectively. The complete set of stimuli was repeated 8-16 times.
We analysed data offline using a custom-written program in Matlab. Voltage signals were high-pass filtered (125 Hz). Spikes were first detected as events exceeding five times the standard deviation of the noise, and then visually verified. Spontaneous spike rate was calculated as the average spike rate during the 2-s time window before the presentation of a visual stimulus. Evoked spike rate was calculated as the average spike rate during the 1.5-s time window of visual stimulation. Overall spike rate was calculated as the average spike rate during the entire recording period. Statistics. All reported sample numbers (n) represent biological replicates. Sample sizes were estimated to have 70-80% power to detect expected effect size using StatMate 2 (GraphPad Software). Statistical analyses used Prism 5 (GraphPad Software) and Matlab. Linear regression with an F-test (two-sided) was used for Fig. 1e and Extended Data Fig. 2a , b. Bootstrapped distributions (Extended Data Fig. 2c ) were used to determine the statistical significance for Fig. 1f . A Wilcoxon matchedpairs signed rank test (two-sided) was used for Figs 2, 3h-j, 4, 5b and Extended Data Fig. 1f are plotted against the average intersoma distance from the same experiment. The average inter-soma distance is the mean of the distances between each pair of pyramidal cells. For the experiments in which only two pyramidal cells were recorded, the inter-soma distance between the two pyramidal cells was used. Lines, linear regression fits. b, The absolute value of the logarithm of the ratio of EPSCs (or IPSCs or E/I ratios) simultaneously recorded in two pyramidal cells was plotted against the inter-somatic distance between the two cells. c, The distribution of E/I ratios across pyramidal cells varies less than if EPSCs and IPSCs were randomly paired between cells and less than the distributions of EPSC and IPSC amplitudes. To determine whether the precise E/I ratio recorded within each pyramidal cell minimizes the average relative deviation, we computed the E/I ratios from randomly but uniquely paired EPSCs and IPSCs within each of the 20 experiments from Fig. 1f . By randomizing within each experiment, we ensured that the average relative deviation was only modified owing to the pairing of EPSCs to IPSCs. Note that, for an experiment with N pyramidal cells, there were N! possible randomized pairings of EPSCs and IPSCs, and hence N! possible E/I ratio average relative deviations (referred to as random-E/I ratio average relative deviations). The distribution of the means of the random-E/I ratio average relative deviations (grey histogram) was constructed from the means of 10,000 samples. Each sample consisted of 20 random-E/I ratio average relative deviations, each of which was randomly chosen from the N! possible random-E/I ratio average relative deviations of each experiment. The grey vertical line represents the mean of the distribution. The distribution of the means of the E/I ratio average relative deviations (black histogram) was generated by bootstrapping (that is, resampling 10,000 times with replacement). Each resample consisted of 20 randomly chosen E/I ratio average relative deviations from the 20 experiments in Fig. 1f , and an E/I ratio average relative deviation was allowed to be repeated within one resample (that is, sampling with replacement). The black vertical line represents the mean of the experimentally obtained E/I ratio average relative deviations. The E/I ratio average relative deviations are smaller than the random-E/I ratio average relative deviations (P , 0.0001). The distributions of the means of the EPSC average relative deviations (red histogram) and the means of the IPSC average relative deviations (blue histogram) were generated by similar bootstrapping to the E/I ratio average relative deviations. The red and blue vertical lines represent the means of the experimentally obtained EPSC average relative deviations and IPSC average relative deviations, respectively. The E/I ratio average relative deviations are smaller than the EPSC average relative deviations (P , 0.0001) and the IPSC average relative deviations (P , 0.0001).

